Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Biohaven Ltd.

NYSE: BHVN · Life Sciences · 5 alerts · CIK 1935979

Share price
$13.80Close, Nov 16
Market cap
$2.08B
Shares outstanding
151.06MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Biohaven Ltd. filings on SEC EDGAR ↗

7:00 AM ET 8-K
Business Update

Biohaven Business Update

Biohaven announced that the FDA has accepted its New Drug Application (NDA) resubmission for Vyglxia (troriluzole) for the treatment of spinocerebellar ataxia (SCA). The FDA has assigned a user fee goal date in the first quarter of 2027 and plans to convene an advisory committee meeting to review the application.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.